Genmab — April 2018
-
Excessive activated T-cell proliferation after anti-CD19 CAR T-cell therapy..."However, excessive activated T-cell proliferation after CAR T-cell infusion dramatically endangered the patient’s life. This risk assessment has now been seriously challenged by our report
of a severe adverse event in our anti-CD19 CAR T-cell therapy trial." -
-
God morgen og tak for links Doc4.

-
Er det godt eller skidt???
-
Som jeg læser det blev patientens liv dramatisk truet efter CAR-T infusion. Dermed skidt for CAR-T og indirekte godt for Darzalex
-
MAS=Macrophage-activation syndrome. https://en.wikipedia.org/wiki/Macrophage_activation_syndrome
-
https://finance.yahoo.com/news/futures-slip-trade-concerns-tech-113603761.html
Vist udløst af Trump angreb på Amazon. -
https://finance.yahoo.com/news/trump-becoming-backfire-president-180050254.html Lidt om den gale mand....
-
Genmab har nu stået pænt imod de seneste gange US er gået i hullet.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind